141 related articles for article (PubMed ID: 2561916)
1. Itraconazole versus ketoconazole for the prophylaxis of fungal infection in neutropenic children: results of two consecutive nonrandomized studies.
Ninane J; Sluysmans T; Vermylen C; De Beule K; Woestenborghs R; Cauwenbergh G; Cornu G
Pediatr Hematol Oncol; 1989; 6(4):349-53. PubMed ID: 2561916
[TBL] [Abstract][Full Text] [Related]
2. Ketoconazole vs. itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies.
Tricot G; Joosten E; Boogaerts MA; Vande Pitte J; Cauwenbergh G
Rev Infect Dis; 1987; 9 Suppl 1():S94-9. PubMed ID: 3027853
[TBL] [Abstract][Full Text] [Related]
3. Antifungal prophylaxis with itraconazole in prolonged neutropenia: correlation with plasma levels.
Boogaerts MA; Verhoef GE; Zachee P; Demuynck H; Verbist L; De Beule K
Mycoses; 1989; 32 Suppl 1():103-8. PubMed ID: 2561181
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of itraconazole in prevention of fungal infections in neutropenic patients.
Thunnissen PL; Sizoo W; Hendriks WD
Neth J Med; 1991 Aug; 39(1-2):84-91. PubMed ID: 1660108
[TBL] [Abstract][Full Text] [Related]
5. Itraconazole in neutropenic patients.
van't Wout JW
Chemotherapy; 1992; 38 Suppl 1():23-6. PubMed ID: 1319311
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of systemic mycoses in neutropenic patients using itraconazole. A comparative, randomized study with amphotericin B].
van't Wout JW; Novakova I; Verhagen CA; Fibbe WE; de Pauw BE; van der Meer JW
Med Klin (Munich); 1991 Dec; 86 Suppl 1():11-3. PubMed ID: 1663200
[TBL] [Abstract][Full Text] [Related]
7. Possible failure of itraconazole in preventing fungal infection in a neutropenic leukaemia patient.
van der Hoven ; Hendriks WD; Sizoo W
Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):202-4. PubMed ID: 1327788
[No Abstract] [Full Text] [Related]
8. Antifungal chemoprophylaxis in cancer children: a prospective randomized controlled study.
Caselli D; Aricò M; Michelone G; Cavanna C; Nespoli L; Burgio GR
Microbiologica; 1990 Oct; 13(4):347-51. PubMed ID: 1965007
[TBL] [Abstract][Full Text] [Related]
9. Antifungal prophylaxis with itraconazole oral solution in neutropenic patients.
Kibbler CC
Mycoses; 1999; 42 Suppl 2():121-4. PubMed ID: 10865918
[TBL] [Abstract][Full Text] [Related]
10. Preliminary results of treatment with itraconazole in patients with systemic fungal infections.
Wolf HH; Scharf RE; Arning M; Schneider W
Haematol Blood Transfus; 1990; 33():560-2. PubMed ID: 2157647
[No Abstract] [Full Text] [Related]
11. Prophylaxis of fungal infections with itraconazole during remission-induction therapy.
Prentice AG; Bradford GR
Mycoses; 1989; 32 Suppl 1():96-102. PubMed ID: 2561190
[TBL] [Abstract][Full Text] [Related]
12. Itraconazole for prophylaxis of systemic mycoses in neutropenic patients with haematological malignancies.
Böhme A; Just-Nübling G; Bergmann L; Shah PM; Stille W; Hoelzer D
J Antimicrob Chemother; 1996 Dec; 38(6):953-61. PubMed ID: 9023642
[TBL] [Abstract][Full Text] [Related]
13. [Prophylaxis of fungal infection in patients with hematologic neoplasms and severe neutropenia after high-dose chemotherapy].
Minenko SV; Zhukov NV; Chimishkian KL; Sokolova EN; Ptushkin VV
Antibiot Khimioter; 2004; 49(8-9):52-6. PubMed ID: 15727147
[TBL] [Abstract][Full Text] [Related]
14. Comparative trial of ketoconazole and nystatin for prevention of fungal infection in neutropenic patients treated in a protective environment.
Shepp DH; Klosterman A; Siegel MS; Meyers JD
J Infect Dis; 1985 Dec; 152(6):1257-63. PubMed ID: 3905986
[TBL] [Abstract][Full Text] [Related]
15. [Itraconazole in the treatment of deep mycoses].
Viviani MA; Tortorano AM
Ann Ist Super Sanita; 1987; 23(4):873-7. PubMed ID: 2837939
[No Abstract] [Full Text] [Related]
16. [Prophylaxis against mycoses in neutropenic patients].
Arning M; Aul C
Mycoses; 1994; 37 Suppl 2():70-6. PubMed ID: 7541892
[TBL] [Abstract][Full Text] [Related]
17. Oral prophylaxis with miconazole or ketoconazole of invasive fungal disease in neutropenic cancer patients.
Meunier-Carpentier F; Cruciani M; Klastersky J
Eur J Cancer Clin Oncol; 1983 Jan; 19(1):43-8. PubMed ID: 6303794
[TBL] [Abstract][Full Text] [Related]
18. Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients.
Glasmacher A; Prentice A; Gorschlüter M; Engelhart S; Hahn C; Djulbegovic B; Schmidt-Wolf IG
J Clin Oncol; 2003 Dec; 21(24):4615-26. PubMed ID: 14673051
[TBL] [Abstract][Full Text] [Related]
19. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
Glasmacher A; Cornely O; Ullmann AJ; Wedding U; Bodenstein H; Wandt H; Boewer C; Pasold R; Wolf HH; Hänel M; Dölken G; Junghanss C; Andreesen R; Bertz H;
J Antimicrob Chemother; 2006 Feb; 57(2):317-25. PubMed ID: 16339606
[TBL] [Abstract][Full Text] [Related]
20. Invasive Aspergillus infection in chronic granulomatous disease: treatment with itraconazole.
Neijens HJ; Frenkel J; de Muinck Keizer-Schrama SM; Dzoljic-Danilovic G; Meradji M; van Dongen JJ
J Pediatr; 1989 Dec; 115(6):1016-9. PubMed ID: 2555469
[No Abstract] [Full Text] [Related]
[Next] [New Search]
